Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00338832 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
A Phase 3 study of Schizophrenia, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT00338832 is a Phase 3 study of Schizophrenia that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 86 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00338832, a Phase 3 study of Schizophrenia, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a lifestyle intervention in increasing physical activity and reducing disease symptoms in sedentary adults with schizophrenia.
Conditions Studied
Interventions
- BEHAVIORAL Physically Ready for Invigorating Movement Every Day (PRIME)
- BEHAVIORAL Program for Activity, Leisure Skills, and Socialization (PALSS)
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00338832
The ClinicalTrials.gov registry entry for NCT00338832 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% lower). The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Physically Ready for Invigorating Movement Every Day (PRIME) is the first listed.
NCT00338832 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00338832 about?
NCT00338832 is a clinical study titled "Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia". This study will evaluate the effectiveness of a lifestyle intervention in increasing physical activity and reducing disease symptoms in sedentary adults with schizophrenia.
What is the current status of trial NCT00338832?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 86 participants. The study started on 2006-06. Estimated completion is 2011-08.
What conditions does trial NCT00338832 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT00338832?
The interventions under investigation include: Physically Ready for Invigorating Movement Every Day (PRIME) (BEHAVIORAL), Program for Activity, Leisure Skills, and Socialization (PALSS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00338832?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00338832 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
-
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
RECRUITING · Phase 3
-
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
RECRUITING · Phase 3
-
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
RECRUITING · Phase 3
-
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.